Proton magnetic resonance spectroscopy shows lower intramyocellular lipid accumulation in middle-aged subjects predisposed to familial longevity

American Journal of Physiology - Endocrinology and Metabolism

Volumn 302, Issue 3, 2012, Pages 344-348

  Wijsman, C A ^a   van Opstal, A M ^a   Kan, H E ^a   Maier, A B ^a   Westendorp, R G J ^a   Slagboom, P E ^a   Webb, A G ^a   Mooijaart, S P ^a   van Heemst, D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aging; Insulin resistance; Metabolism; Skeletal muscle

Indexed keywords

CREATININE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CELLULAR PARAMETERS; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; HYPERINSULINEMIC EUGLYCEMIC CLAMP; INTERANATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE; INTRAMYOCELLULAR LIPID ACCUMULATION; LONGEVITY; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGENY; PROTON NUCLEAR MAGNETIC RESONANCE; QUESTIONNAIRE; SEX DIFFERENCE; SIBLING; TIBIALIS ANTERIOR MUSCLE;

ADULT CHILDREN; AGED; BODY MASS INDEX; COHORT STUDIES; FAMILY HEALTH; FEMALE; HUMANS; INSULIN RESISTANCE; LEG; LIPID METABOLISM; LONGEVITY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MOTOR ACTIVITY; MUSCLE FIBERS, SKELETAL; NETHERLANDS; QUESTIONNAIRES; SIBLINGS;

EID: 84856166531     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00455.2011     Document Type: Article

References (33)

1. Boesch C, Machann J, Vermathen P, Schick F. Role of proton MR for the study of muscle lipid metabolism. NMR Biomed 19: 968-988, 2006.
2. De Feyter HM, van den Broek NM, Praet SF, Nicolay K, van Loon LJ, Prompers JJ. Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction. Eur J Endocrinol 158: 643-653, 2008.
3. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 86: 3574-3578, 2001.
4. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34: 416-422, 1991.
5. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 45: 947-953, 1996.
6. Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86: 5755-5761, 2001.
7. Hagströmer M, Oja P, Sjöström M. The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity. Public Health Nutr 9: 755-762, 2006.
8. Hanstock CC, Thompson RB, Trump ME, Gheorghiu D, Hochachka PW, Allen PS. Residual dipolar coupling of the Cr/PCr methyl resonance in resting human medial gastrocnemius muscle. Magn Reson Med 42: 421-424, 1999.
9. Haugaard SB, Mu H, Vaag A, Madsbad S. Intramyocellular triglyceride content in man, influence of sex, obesity and glycaemic control. Eur J Endocrinol 161: 57-64, 2009.
10. Hwang JH, Pan JW, Heydari S, Hetherington HP, Stein DT. Regional differences in intramyocellular lipids in humans observed by in vivo 1H-MR spectroscopic imaging. J Appl Physiol 90: 1267-1274, 2001.
11. Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schick F, Claussen CD, Häring HU. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48: 1113-1119, 1999.
12. Kelso TB, Hodgson DR, Visscher AR, Gollnick PD. Some properties of different skeletal muscle fiber types: comparison of reference bases. J Appl Physiol 62: 1436-1441, 1987.
13. Kreis R, Kamber M, Koster M, Felblinger J, Slotboom J, Hoppeler H, Boesch C. Creatine supplementation-part II: in vivo magnetic resonance spectroscopy. Med Sci Sports Exerc 31: 1770-1777, 1999.
14. Paolisso G, Gambardella A, Ammendola S, D'Amore A, Balbi V, Varricchio M, D'Onofrio F. Glucose tolerance and insulin action in healty centenarians. Am J Physiol Endocrinol Metab 270: E890-E894, 1996.
15. Perseghin G, Lattuada G, Danna M, Sereni LP, Maffi P, De Cobelli F, Battezzati A, Secchi A, Del Maschio A, Luzi L. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 285: E1174-E1181, 2003.
16. Perseghin G, Petersen K, Shulman GI. Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord 27, Suppl 3: S6-S11, 2003.
17. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300: 1140-1142, 2003.
18. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664-671, 2004.
19. Ren J, Sherry AD, Malloy CR. 1H MRS of intramyocellular lipids in soleus muscle at 7 T: spectral simplification by using long echo times without water suppression. Magn Reson Med 64: 662-671, 2010.
20. Rozing MP, Westendorp RG, de Craen AJ, Frölich M, de Goeij MC, Heijmans BT, Beekman M, Wijsman CA, Mooijaart SP, Blauw GJ, Slagboom PE, van Heemst D; Leiden Longevity Study Group. Favorable glucose tolerance and lower prevalence of metabolic syndrome in offspring without diabetes mellitus of nonagenarian siblings: the Leiden longevity study. J Am Geriatr Soc 58: 564-569, 2010.
21. Rozing MP, Westendorp RG, Frölich M, de Craen AJ, Beekman M, Heijmans BT, Mooijaart SP, Blauw GJ, Slagboom PE, van Heemst D; Leiden Longevity Study (LLS) Group. Human insulin/IGF-1 and familial longevity at middle age. Aging (Albany NY) 1: 714-722, 2009.
22. Salgin B, Sleigh AJ, Williams RM, Jackson SJ, Bluck LJ, Murgatroyd PR, Humphreys SM, Harding S, Carpenter TA, Dunger DB. Intramyocellular lipid levels are associated with peripheral, but not hepatic, insulin sensitivity in normal healthy subjects. Clin Sci (Lond) 117: 111-118, 2009.
23. Schär M, Kozerke S, Fischer SE, Boesiger P. Cardiac SSFP imaging at 3 Tesla. Magn Reson Med 51: 799-806, 2004.
24. Schoenmaker M, de Craen AJ, de Meijer PH, Beekman M, Blauw GJ, Slagboom PE, Westendorp RG. Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. Eur J Hum Genet 14: 79-84, 2006.
25. Schrauwen P. High-fat diet, muscular lipotoxicity and insulin resistance. Proc Nutr Soc 66: 33-41, 2007.
26. Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Echteld CJ, van Engelshoven JM, Mensink M, Schrauwen P. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 50: 113-120, 2007.
27. Thamer C, Machann J, Bachmann O, Haap M, Dahl D, Wietek B, Tschritter O, Niess A, Brechtel K, Fritsche A, Claussen C, Jacob S, Schick F, Häring HU, Stumvoll M. Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 88: 1785-1791, 2003.
28. van Loon LJ, Goodpaster BH. Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state. Pflugers Arch 451: 606-616, 2006.
29. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129: 35-43, 1997.
30. Vermathen P, Kreis R, Boesch C. Distribution of intramyocellular lipids in human calf muscles as determined by MR spectroscopic imaging. Magn Reson Med 51: 253-262, 2004.
31. Versluis MJ, Kan HE, van Buchem MA, Webb AG. Improved signal to noise in proton spectroscopy of the human calf muscle at 7 T using localized B1 calibration. Magn Reson Med 63: 207-211, 2010.
32. Westendorp RG, van Heemst D, Rozing MP, Frölich M, Mooijaart SP, Blauw GJ, Beekman M, Heijmans BT, de Craen AJ, Slagboom PE; Leiden Longevity Study Group. Nonagenarian siblings and their offspring display lower risk of mortality and morbidity than sporadic nonagenarians: The Leiden Longevity Study. J Am Geriatr Soc 57: 1634-1637, 2009.
33. Wijsman CA, Rozing MP, Streefland TC, le Cessie S, Mooijaart SP, Slagboom PE, Westendorp RG, Pijl H, van Heemst D; Leiden Longevity Study group. Familial longevity is marked by enhanced insulin sensitivity. Aging Cell 10: 114-121, 2011.